Baghi, S. G., Alavian, S. M., Mehrnoush, L., & Salimi, S. (2015). Impact of the IL–10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection, 15(7). http://doi.org/10.5812/hepatmon.28287v2
Cheong, J., Cho, S., Hwang, I., Yoon, S., Lee, J., Park, C., … Kim, J. (2006). Association between chronic hepatitis B virus infection and interleukin–10, tumor necrosis factor-α gene promoter polymorphisms. J Gastroenterol Hepatol., 21, 1163–9.
Dondeti, M. F., El-maadawy, E. A., & Talaat, R. M. (2016). Hepatitis-related hepatocellular carcinoma : Insights into cytokine gene polymorphisms, 22(30), 6800–6816. http://doi.org/10.3748/wjg.v22.i30.6800
Elmer, P., Tuncbilek, S., Aydin, K., & Hizel, K. (2013). Vitamin D and Tumor Necrosis Factor-Alpha Receptor Gene Polymorphisms in Various Hepatitis B Clinical Conditions in Turkey, 6(5), 185–190.
Falleti, E., Bitetto, D., Fabris, C., Cussigh, A., Fontanini, E., Fornasiere, E., … Fontanini, E. (2010). Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis, 16(24), 3016–3024. http://doi.org/10.3748/wjg.v16.i24.3016
Fletcher, G. J., Samuel, P., Christdas, J., Gnanamony, M., Ismail, A.M., Anantharam, R., … Abraham, P. (2011). Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes and Immunity, 12(7), 552–558. http://doi.org/10.1038/gene.2011.32
Gao, L., Chen, X., Zhang, L., Wu, D., Zhao, H., & Niu, J. (2016). Association of IL ‑ 10 polymorphisms with hepatitis B virus infection and outcome in Han population. Eu J Med Res, 1–6. http://doi.org/10.1186/s40001–016–0218–9
Gao, Q., Xie, J., Wang, L., Zhou, Q., Zhang, S., & L-m, W. (2017). Interaction effects among IFN-γ + 874, IL- polymorphisms on the clinical progression of subjects infected with hepatitis B virus and / or hepatitis C virus : a retrospective nested case—control study, 2, 1–7. http://doi.org/10.1136/bmjopen–2016–013279
Ge, D., Fellay, J., Thompson, A., Simon, J., Shianna, K., Urban, T., … Qiu, P. (2009). Genetic variation in IL–28B predicts hepatitis B treatment-induced viral clearance. Nature, 461, 399–401.
Gusatti, C. de S., Costi, C., Rubia, M., Halon, L., Grandi, T., Ferrari, A., … Rodenbusch, R. (2016). Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil Association Between Cytokine Gene Polymorphisms and Outcome of Hepatitis B Virus Infection in. Journal of Medical Virology, (March). http://doi.org/10.1002/jmv.24518
Heidari, Z., Moudi, B., Sagheb, H. M., & Moudi, M. (2016). Association of TNF- α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population, 16(11). http://doi.org/10.5812/hepatmon.41984.Research
Kao, P., Wu, J., Ni, Y., Lin, Y., Chen, H., & Hsu, S. (2010). Tumour necrosis factor-alpha promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver International, 30, 1448–1453.
Kim, Y. J., Lee, H., Yoon, J., Kim, C. Y., Park, M. H., Kim, L. H., … Shin, H. D. (2018). Association of TNF- a promoter polymorphisms with the clearance of hepatitis B virus infection, 12(19), 2541–2546. http://doi.org/10.1093/hmg/ddg262
Kruger, A., Gerken, G., Schneider, P.M., & Bu, K. M. Z. U. M. (1998). A tumour necrosis factor-alpha ( TNF- a) promoter polymorphism is associated with chronic hepatitis B infection, 579–582.
Li, H., Li, Z., Liu, Y., Li, J., Dong, J., & Gao, J. (2005). Association of polymorphism of tumour necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol, 11, 5213–5217.
Manjita, S., Arttrika, R., Jitendra, K. C., Manish, K. T., Smita, V., Vinod, K. D., … Ashok, K. J. (2014). Role of Proinflammatory Cytokines (Interferon Gamma) and Anti Inflammatory Cytokine (Interleukin–10) Gene Polymorphisms in Chronic Hepatitis B Infection: An Indian Scenario. JOURNAL OF INTERFERON & CYTOKINE RESEARCH, 34(7), 547–551.
Migita, K., Miyazoe, S., Maeda, Y., Daikoku, M., Abiru, S., Ueki, T., … Eguchi, K. (2005). Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection—association between TGF- b 1 polymorphisms and hepatocellular carcinoma, 42, 505–510. http://doi.org/10.1016/j.jhep.2004.11.026
Moudi, B., Heidari, Z., Mahmoudzadeh-sagheb, H., Hashemi, M., Metanat, M., Khosravi, S., & Farrokh, P. (2016). Association Between IL–10 Gene Promoter Polymorphisms ( –592 A / C, –819 T / C, –1082 A / G) and Susceptibility to HBV Infection in an Iranian Population, 16(2). http://doi.org/10.5812/hepatmon.32427
Ognjanovic, S., Yuan, J., Chaptman, A. K., Fan, Y., & Yu, M. C. (2009). Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA, 30(5), 758–762. http://doi.org/10.1093/carcin/bgn286
Panigrahi, R., Sarkar, N., Biswas, A., Pal, A., Saha, D., Singh, S. P., … Chakravarty, R. (2014). Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India. Journal of Clinical and Experimental Hepatology, 4(3), 202–208. http://doi.org/10.1016/j.jceh.2014.08.002
Peng, Q., Yang, S., Lao, X., Li, R., Chen, Z., Wang, J., … Li, S. (2014). Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population. PLoS ONE, 9(12), 1–17. http://doi.org/10.1371/journal.pone.0116026
Sofian, M., Kalantar, E., Aghakhani, A., Hosseini, S., Eslamifar, A., Farazi, A. A., & Ramezani, A. (2013). No Correlation Between Interleukin–10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome, 13(5). http://doi.org/10.5812/hepatmon.8803
Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assesment of the quality of non-randomised studies in meta-analysis of genome searches. Genet Epidemiol, 25, 603–605.
Sun, Y., Lu, Y., Li, T., Xie, L., Deng, Y., Li, S., & Qin, X. (2015). Interferon Gamma + 874T / A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases : Evidence from a Meta-Analysis, 1–15. http://doi.org/10.1371/journal.pone.0121168
Suneetha, P. V., Sarin, S. K., Goyal, A., Kumar, G. T., Shukla, D. K., & Hissar, S. (2006). Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease. Journal of Hepatology, 44(5), 856–863. http://doi.org/10.1016/j.jhep.2006.01.028
Tumer, D., William, D., Sankaran, D., Lazarus, M., & Sinnott, P. (1997). An investigation of polymorphism in the interleukin–10 gene promoter. Eur J Immunogenet, 24(1), 1–8.
Wang, C., Zhang, X., Zhu, B., Hu, D., Wu, J., Yu, R., & Zhao, W. (2012). Relationship between tumour necrosis factor-alpha, interleukin–12B and interleukin–10 gene polymorphisms and hepatitis B in Chinese Han haemodialysis patients. Nephrology, 17, 167–174.
Wang, F. (2003). Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection, 9(4), 641–644.
Wang, S., Huang, D., Sun, S., Ma, W., & Zhen, Q. (2011). Interleukin–10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J, 8, 28.
Wei, M., Liu, B., & Chen, X. (2011). Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic Review and Meta-analysis. Dig Dis Sci, 56(8), 2227–2236.
Yao, L., Xing, S., Fu, X., Song, H., Wang, Z., Tang, J., & Zhao, Y. (2015). Association between interleukin–10 gene promoter polymorphisms and susceptibility to liver cirrhosis, 8(December 2014), 11680–11684.
Yao, X., Zeng, H., Zhang, G., Zhou, W., Yan, Q., Dai, L., & Wang, X. (2013). The Associated Ion between the VDR Gene Polymorphisms and Susceptibility to Hepatocellular Carcinoma and the Clinicopathological Features in Subjects Infected with HBV, 2013.
Zheng, M., Qiu, L., Xin, Y., Pan, H., Shi, K., & Chen, Y. (2010). Tumour necrosis factor-alpha–308A allele may have protective effect for chronic hepatitis B virus infection in Mongoloid population. Int. J Infect Dis, 14(7), 580–585.
Zintzaras, E., & JP, L. (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123–137.